As we have previously reported here on Wake Up World, psilocybin (magic mushrooms) and MDMA (ecstasy) have both recently been granted Breakthrough Status by the FDA, a designation given to drugs with clinically significant and potentially far reaching benefits. Psilocybin is heading towards phase 3 human trials as a treatment for major depressive disorder, while MDMA is close to approval as a PTSD treatment.
Specifically, the study set out to explore the types of autonomous entity encounters people have after smoking DMT. Previous studies have revealed a large volume of anecdotal evidence for such entity encounters.
In particular, the landmark work of Rick Strassman in 1990 detailed such encounters in-depth, and his book, DMT: The Spirit Molecule spoke of alien-type, unsettling encounters where participants were probed or otherwise had negative or frightening interactions with entities. The Center’s new study, however, reveals that although these types of encounter are reported, they are in a minority...<<<Read The Full Article Here>>>..
